# Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors

> **NCT00837928** · PHASE1 · COMPLETED · sponsor: **John Grecula** · enrollment: 18 (actual)

## Conditions studied

- Metastatic Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** bendamustine
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** Surgical Resection of Brain Metastases
- **RADIATION:** Stereotactic body radiation therapy

## Key facts

- **NCT ID:** NCT00837928
- **Lead sponsor:** John Grecula
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02-19
- **Primary completion:** 2015-01-08
- **Final completion:** 2015-01-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00837928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00837928, "Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00837928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*